Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 févr. 2026 20h51 HE | Source: Hims

Hims GLP-1 Weight Loss: What Consumers Should Know About the Reported $49 Compounded Semaglutide Pill, Novo Nordisk Response, and Telehealth Prescription Access in 2026

Hims GLP-1 weight loss update: reported $49 compounded semaglutide pill, FDA vs. compounded distinctions, and telehealth access details for 2026
28 janv. 2026 18h03 HE | Source: TomorrowRX

TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations

TomorrowsRx platform details prescription access process for compounded semaglutide & tirzepatide formulations through telehealth evaluation.
10 juin 2025 19h26 HE | Source: Mochi Health

Mochi Health Launches Enhanced Online Platform to Support Medical Weight Loss Patients Nationwide

SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth company delivering medical weight loss care directly to patients, announced today the launch of its...
25 avr. 2025 17h48 HE | Source: TMates

TMates Under Review: Affordable GLP-1 Medication Website to Buy Semaglutide, Tirzepatide, Phentermine & More

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why traditional weight loss methods often fail due to metabolic resistance, hormonal imbalances, and emotional...